Call Options

26 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.7 - $2.39 $207,230 - $291,341
-121,900 Reduced 66.39%
61,700 $107,000
Q2 2024

Aug 15, 2024

BUY
$1.62 - $2.04 $251,262 - $316,404
155,100 Added 544.21%
183,600 $323,000
Q1 2024

May 07, 2024

BUY
$1.66 - $2.42 $5,976 - $8,712
3,600 Added 14.46%
28,500 $53,000
Q4 2023

Feb 14, 2024

BUY
$1.25 - $2.35 $7,375 - $13,865
5,900 Added 31.05%
24,900 $53,000
Q3 2023

Nov 14, 2023

BUY
$1.5 - $3.07 $7,350 - $15,043
4,900 Added 34.75%
19,000 $30,000
Q2 2023

Aug 11, 2023

SELL
$1.79 - $2.9 $75,717 - $122,670
-42,300 Reduced 75.0%
14,100 $34,000
Q1 2023

May 16, 2023

BUY
$2.65 - $3.81 $3,180 - $4,572
1,200 Added 2.17%
56,400 $167,000
Q4 2022

Feb 14, 2023

SELL
$3.38 - $4.22 $474,890 - $592,910
-140,500 Reduced 71.79%
55,200 $201,000
Q3 2022

Nov 14, 2022

SELL
$3.43 - $5.83 $439,383 - $746,823
-128,100 Reduced 39.56%
195,700 $705,000
Q2 2022

Aug 15, 2022

BUY
$4.41 - $5.69 $340,011 - $438,699
77,100 Added 31.25%
323,800 $1.71 Million
Q1 2022

May 16, 2022

BUY
$4.81 - $6.99 $340,067 - $494,193
70,700 Added 40.17%
246,700 $1.35 Million
Q4 2021

Feb 14, 2022

SELL
$5.97 - $7.93 $233,427 - $310,063
-39,100 Reduced 18.18%
176,000 $1.2 Million
Q3 2021

Nov 15, 2021

SELL
$4.79 - $6.68 $253,391 - $353,372
-52,900 Reduced 19.74%
215,100 $1.31 Million
Q2 2021

Aug 11, 2021

BUY
$5.35 - $6.35 $549,445 - $652,145
102,700 Added 62.13%
268,000 $1.58 Million
Q1 2021

May 17, 2021

SELL
$5.68 - $7.87 $166,992 - $231,378
-29,400 Reduced 15.1%
165,300 $993,000
Q4 2020

Feb 16, 2021

SELL
$5.25 - $8.56 $673,050 - $1.1 Million
-128,200 Reduced 39.7%
194,700 $1.35 Million
Q3 2020

Nov 16, 2020

BUY
$5.78 - $7.47 $679,728 - $878,472
117,600 Added 57.28%
322,900 $2.02 Million
Q2 2020

Aug 14, 2020

BUY
$4.5 - $7.02 $711,000 - $1.11 Million
158,000 Added 334.04%
205,300 $1.36 Million
Q1 2020

May 15, 2020

SELL
$2.87 - $5.49 $49,938 - $95,526
-17,400 Reduced 26.89%
47,300 $220,000
Q3 2019

Nov 14, 2019

SELL
$4.86 - $6.05 $619,650 - $771,375
-127,500 Reduced 66.34%
64,700 $334,000
Q2 2019

Aug 14, 2019

SELL
$4.51 - $6.6 $64,042 - $93,720
-14,200 Reduced 6.88%
192,200 $1.08 Million
Q1 2019

May 15, 2019

BUY
$5.16 - $6.85 $889,068 - $1.18 Million
172,300 Added 505.28%
206,400 $1.29 Million
Q4 2018

Feb 14, 2019

SELL
$4.89 - $7.16 $188,265 - $275,660
-38,500 Reduced 53.03%
34,100 $173,000
Q3 2018

Nov 14, 2018

SELL
$6.89 - $7.78 $670,397 - $756,994
-97,300 Reduced 57.27%
72,600 $523,000
Q2 2018

Aug 14, 2018

BUY
$5.19 - $7.25 $269,880 - $377,000
52,000 Added 44.11%
169,900 $1.13 Million
Q1 2018

May 15, 2018

BUY
$3.56 - $5.74 $419,724 - $676,746
117,900 New
117,900 $646,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $301M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.